 [2007-1-1]Effect of Single-Agent Rituximab Given at the Standard Schedule or As Prolonged Treatment in Patients With Mantle Cell Lymphoma: A Study of |
| [2007-1-1]Rituximab in Combination With Fludarabine Chemotherapy in Low-Grade or Follicular Lymphoma |
| [2007-1-1]Phenotypic Heterogeneity in Multiple Myeloma Families |
| [2007-1-1]Phase II Clinical Experience With the Novel Proteasome Inhibitor Bortezomib in Patients With Indolent Non-Hodgkin's Lymphoma and Mantle Cell |
| [2007-1-1]Phase II Study of Proteasome Inhibitor Bortezomib in Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma |
| [2007-1-1]Phase I and Pharmacokinetic Study of Oral Irinotecan Given Once Daily for 5 Days Every 3 Weeks in Combination With Capecitabine in Patients |
| [2007-1-1]Attitudes of Patients With Incurable Cancer Toward Medical Treatment in the Last Phase of Life |
| [2007-1-1]Osteosarcoma: A Randomized, Prospective Trial of the Addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin, and High-Do |
| [2007-1-1]Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation With Nonmyeloablative Conditioning |
| [2007-1-1]Immunochemotherapy With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Significantly Improves Response and Time to |
| [2007-1-1]Clinical Activity of Rituximab in Gastric Marginal Zone Non-Hodgkin's Lymphoma Resistant to or Not Eligible for Anti–Helicobacter Pylori The |
| [2007-1-1]Prognostic Index for Adult Patients With Acute Myeloid Leukemia in First Relapse |
| [2007-1-1]Paclitaxel Decreases the Interstitial Fluid Pressure and Improves Oxygenation in Breast Cancers in Patients Treated With Neoadjuvant Chemoth |
| [2007-1-1]Pattern of Prostate-Specific Antigen (PSA) Failure Dictates the Probability of a Positive Bone Scan in Patients With an Increasing PSA After |
| [2007-1-1]Evolving Treatment Strategies for Inflammatory Breast Cancer: A Population-Based Survival Analysis |
| [2007-1-1]Sequencing of Chemotherapy and Radiation Therapy in Early-Stage Breast Cancer: Updated Results of a Prospective Randomized Trial |
| [2007-1-1]Evolving Treatment Strategies for Inflammatory Breast Cancer: A Population-Based Survival Analysis |
| [2007-1-1]Implications of the Prostate Cancer Prevention Trial: A Decision Analysis Model of Survival Outcomes |
| [2007-1-1]EGR1 Predicts PTEN and Survival in Patients With Non–Small-Cell Lung Cancer |
| [2007-1-1]Risk Markers of Oral Cancer in Clinically Normal Mucosa As an Aid in Smoking Cessation Counseling |
| [2007-1-1]Clinical Characteristics of Pheochromocytoma Patients With Germline Mutations in SDHD |
| [2007-1-1]Psychological Impact of Genetic Testing for Hereditary Nonpolyposis Colorectal Cancer |
| [2007-1-1]Trabectedin for Women With Ovarian Carcinoma After Treatment With Platinum and Taxanes Fails |
| [2007-1-1]Phase I and Pharmacologic Study of 17-(Allylamino)-17-Demethoxygeldanamycin in Adult Patients With Solid Tumors |
| [2007-1-1]Impact of Short-Term Preoperative Radiotherapy on Health-Related Quality of Life and Sexual Functioning in Primary Rectal Cancer: Report of |
| [2007-1-1]Phase I Trial of the Cyclin-Dependent Kinase Inhibitor and Protein Kinase C Inhibitor 7-Hydroxystaurosporine in Combination With Fluorouraci |
| [2007-1-1]Randomized Trial of Two Intravenous Schedules of the Topoisomerase I Inhibitor Liposomal Lurtotecan in Women With Relapsed Epithelial Ovaria |
| [2007-1-1]Effectiveness of Gene Expression Profiling for Response Prediction of Rectal Adenocarcinomas to Preoperative Chemoradiotherapy |
| [2007-1-1]Phase III Southwest Oncology Group 9415/Intergroup 0153 Randomized Trial of Fluorouracil, Leucovorin, and Levamisole Versus Fluorouracil Con |
| [2007-1-1]Impact of Short-Term Preoperative Radiotherapy on Health-Related Quality of Life and Sexual Functioning in Primary Rectal Cancer: Report of |
| [2007-1-1]Phase II Study of Radiotherapy Employing Proton Beam for Hepatocellular Carcinoma |
| [2007-1-1]Role of Transforming Growth Factor Beta in Human Cancer |
| [2007-1-1]Expression of the Caudal-Type Homeodomain Transcription Factors CDX 1/2 and Outcome in Carcinomas of the Ampulla of Vater |
| [2007-1-1]Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistoch |
| [2007-1-1]What Is Targeted Therapy |
| [2007-1-1]Moving Away From the "One Shoe Fits All" Strategy: The Key to Future Progress in Chemotherapy |
| [2007-1-1]Optimizing Endocrine Therapy for Breast Cancer |
| [2007-1-1]Radiation Therapy for Invasive Breast Cancer: Not Just for Local Control |
| [2007-1-1]Continuing Evolution in Breast Cancer Surgical Management |
| [2007-1-1]Integration of Imaging in the Management of Breast Cancer |
| [2007-1-1]Chemoprevention in the 21st Century: Is a Balance Best or Should Women Have No Estrogen at All |
| [2007-1-1]Pivotal Study of Iodine-131–Labeled Chimeric Tumor Necrosis Treatment Radioimmunotherapy in Patients With Advanced Lung Cancer |
| [2007-1-1]Prognostic and Predictive Factors for Breast Cancer: Translating Technology to Oncology |
| [2007-1-1]Health Care Provider-Directed Intervention to Increase Colorectal Cancer Screening Among Veterans: Results of a Randomized Controlled Trial |
| [2007-1-1]High Risk of Brain Metastases in Surgically Staged IIIA Non–Small-Cell Lung Cancer Patients Treated With Surgery, Chemotherapy, and Radiatio |
| [2007-1-1]Salvage Radiotherapy in Patients With Relapsed and Refractory Hodgkin’s Lymphoma: A Retrospective Analysis From the German Hodgkin Lymphoma |
| [2007-1-1]Common Polymorphism G(-248)A in the Promoter Region of the bax Gene Results in Significantly Shorter Survival in Patients With Chronic Lymph |
| [2007-1-1]Results of Whole-Brain Radiation As Salvage of Methotrexate Failure for Immunocompetent Patients With Primary CNS Lymphoma |
| [2007-1-1]Rituximab Plus Short-Duration Chemotherapy As First-Line Treatment for Follicular Non-Hodgkin’s Lymphoma: A Phase II Trial of the Minnie Pea |
| [2007-1-1]Atypical Teratoid/Rhabdoid Tumors (ATRT): Improved Survival in Children 3 Years of Age and Older With Radiation Therapy and High-Dose Alkyla |
| [2007-1-1]Prognostic Significance of Activated Akt Expression in Melanoma: A Clinicopathologic Study of 292 Cases |
| [2007-1-1]TP53 Mutations and Outcome in Osteosarcoma: A Prospective, Multicenter Study |
| [2007-1-1]Plasma Bikunin As a Favorable Prognostic Factor in Ovarian Cancer |
| [2007-1-1]Preoperative Serum Squamous Cell Carcinoma Antigen Levels in Clinical Decision Making for Patients With Early-Stage Cervical Cancer |
| [2007-1-1]Dietary Counseling Improves Patient Outcomes: A Prospective, Randomized, Controlled Trial in Colorectal Cancer Patients Undergoing Radiother |
| [2007-1-1]Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer |
| [2007-1-1]Supradose Intra-Arterial Cisplatin and Concurrent Radiation Therapy for the Treatment of Stage IV Head and Neck Squamous Cell Carcinoma Is F |
| [2007-1-1]Multi-Institutional Randomized Phase II Trial of the Epothilone B Analog Ixabepilone (BMS-247550) With or Without Estramustine Phosphate in |
| [2007-1-1]Site of Primary Tumor Has a Prognostic Role in Operable Breast Cancer: The International Breast Cancer Study Group Experience |
| [2007-1-1]Postmastectomy Radiation and Mortality in Women With T1-2 Node-Positive Breast Cancer |
| [2007-1-1]Gemcitabine, Epirubicin, and Paclitaxel Versus Fluorouracil, Epirubicin, and Cyclophosphamide As First-Line Chemotherapy in Metastatic Breas |
| [2007-1-1]Size of Breast Cancer Metastases in Axillary Lymph Nodes: Clinical Relevance of Minimal Lymph Node Involvement |
| [2007-1-1]Weight, Weight Gain, and Survival After Breast Cancer Diagnosis |
| [2007-1-1]Phase I Trial of Capecitabine and Weekly Irinotecan in Combination With Radiotherapy for Neoadjuvant Therapy of Rectal Cancer |
| [2007-1-1]Weight, Weight Gain, and Survival After Breast Cancer Diagnosis |
| [2007-1-1]Predictors of Survival After Radiofrequency Thermal Ablation of Colorectal Cancer Metastases to the Liver: A Prospective Study |
| [2007-1-1]Intrathecal Mafosfamide: A Preclinical Pharmacology and Phase I Trial |
| [2007-1-1]Randomized Phase III Study of Matrix Metalloproteinase Inhibitor BMS-275291 in Combination With Paclitaxel and Carboplatin in Advanced Non-S |
| [2007-1-1]Efficacy and Tolerability of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer After |
| [2007-1-1]Diagnostic Performance of Nanoparticle-Enhanced Magnetic Resonance Imaging in the Diagnosis of Lymph Node Metastases in Patients With Endome |
| [2007-1-1]Phase I Study of BMS-214662, a Farnesyl Transferase Inhibitor in Patients With Acute Leukemias and High-Risk Myelodysplastic Syndromes |
| [2007-1-1]Diffuse Large B-Cell Lymphoma: Clinical and Biological Characterization and Outcome According to the Nodal or Extranodal Primary Origin |
| [2007-1-1]Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer: Impact of Patient Selection Factors on Outcome |
| [2007-1-1]Docetaxel Followed by Hormone Therapy in Men Experiencing Increasing Prostate-Specific Antigen After Primary Local Treatments for Prostate C |
| [2007-1-1]Chemokine Receptor CXCR4 Expression in Colorectal Cancer Patients Increases the Risk for Recurrence and for Poor Survival |
| [2007-1-1]Long-Term Outcomes Among Localized Prostate Cancer Survivors: Health-Related Quality-of-Life Changes After Radical Prostatectomy, External R |
| [2007-1-1]Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience |
| [2007-1-1]Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate in Patients With Endocrine Gastroenteropancreatic Tumors |
| [2007-1-1]Familial Gastrointestinal Stromal Tumor Syndrome: Phenotypic and Molecular Features in a Kindred |
| [2007-1-1]Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, in Metastatic and Locally Advanced Breast Cancer |
